Krystal Biotech Inc (NASDAQ:KRYS)
| 73.95 Delayed Data As of Aug 17 |  -2.05 / -2.70%Today’s Change | 38.86 Today|||52-Week Range 102.99 | +5.72% Year-to-Date |
Latest KRYS News | Press Releases
No recent news for Krystal Biotech Inc.
Today’s Trading
| Previous close | 76.00 |
| Today’s open | 75.69 |
| Day’s range | 73.61 - 76.33 |
| Volume | 3,919 |
| Average volume (3 months) | 173,648 |
| Market cap | $2.0B |
Data as of 3:59pm ET, 08/17/2022
Growth & Valuation
| Earnings growth (last year) | -83.05% |
| Earnings growth (this year) | -68.19% |
| Earnings growth (next 5 years) | -20.10% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OPKOPKO Health Inc | -0.04 | -1.54% |
| --Almirall SA | 0.00 | 0.00% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 08/17/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$1.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$69.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pittsburgh, Pennsylvania |
Forecasts
